|
Fracture risk prediction using circulating F2-isoprostanes
RPI ID:
2024-023-301
Innovation Summary:
This technology provides systems and methods for assessing fracture risk by measuring circulating levels of F2-isoprostanes, which are biomarkers of oxidative stress. The approach integrates biochemical analysis with predictive modeling to evaluate bone fragility. It enables early identification of individuals...
Published: 3/10/2026
|
Updated: 3/10/2026
|
Inventor(s): Bowen Wang, Deepak Vashishth
Keywords(s): bone mineral density, f2-isoprostanes, Fracture Risk, oxidative stress
Category(s): Biotechnology and the Life Sciences
|
